DalsnaFinance › Analyst accuracy › Wolfe Research › ABBV target
Biogen (BIIB) and AbbVie (ABBV) Get Wolfe Upgrades—Which Pharma Stock Has More Upside?
with Wolfe assigning them similar $300 price targets.
A fact about what Wolfe Research published, as reported by Yahoo Finance, not a recommendation from Dalsna Finance; Wolfe Research is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.